Here's a look at some of the top Wall Street stories for medical device companies this week: Is Boston Scientific's peripherals buy bad news for Cardiovascular Systems?; M&A: Medtech makers use acquisitions to fill niches; Report: Deals in the medical device sector rose 200% in Q1; CareFusion plans $1B debt offering; Activist investor Oracle revives proxy war at Biolase.
Is Boston Scientific's peripherals buy bad news for Cardiovascular Systems?
May 15, 2014 by Arezu Sarvestani
Bayer HealthCare, Biolase Technology Inc., Boston Scientific, Cardiovascular Systems Inc., CareFusion Corp., Oracle Partners, PricewaterhouseCoopers (PwC), Walden Group
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1vLQWyL
Cap comentari:
Publica un comentari a l'entrada